ARROWHEAD PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares.
- ARROWHEAD PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-04 | 0.00 shares 10-Q · filed 2026-08-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-02-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-05 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-04 | 0.00 shares 10-K · filed 2025-11-25 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-04 | 0.00 shares 10-Q · filed 2026-08-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | 0.00 shares 10-Q · filed 2026-02-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-05 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-05 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-05 | ||
| 2024-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-25 | 0.00 shares derived: sum of 3 quarters · filed 2025-11-25 | 0.00 shares 10-K · filed 2025-11-25 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-12 | 0.00 shares 10-Q · filed 2024-08-08 | -32.15K shares derived: sum of 4 quarters · filed 2025-11-25 | ||
| 2024-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-12 | 0.00 shares 10-Q · filed 2025-05-12 | -32.15K shares derived: sum of 3 quarters · filed 2025-11-25 | 0.00 shares derived: sum of 4 quarters · filed 2025-11-25 | ||
| 2023-12-31 | 0.00 shares 10-Q · filed 2025-02-10 | -32.15K shares derived: sum of 2 quarters · filed 2025-11-25 | 0.00 shares derived: sum of 3 quarters · filed 2025-11-25 | 0.00 shares derived: sum of 4 quarters · filed 2025-11-25 | ||
| 2023-09-30 | -32.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-25 | 0.00 shares derived: sum of 3 quarters · filed 2025-11-25 | 0.00 shares 10-K · filed 2025-11-25 | 32.15K shares 10-K · filed 2023-11-29 | |
| 2023-06-30 | 32.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | 32.15K shares derived: sum of 2 quarters · filed 2024-05-09 | 32.15K shares 10-Q · filed 2023-08-07 | 32.15K shares derived: sum of 4 quarters · filed 2024-11-26 | ||
| 2023-03-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | 0.00 shares 10-Q · filed 2024-05-09 | 32.15K shares 10-Q · filed 2023-05-02 | 0.00 shares derived: sum of 3 quarters · filed 2024-11-26 | ||
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-02-06 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-26 | ||||
| 2022-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | 0.00 shares 10-K · filed 2024-11-26 | ||||
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-04 | |||||
| 2021-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22 | 18.00K shares derived: sum of 2 quarters · filed 2021-11-22 | 42.00K shares derived: sum of 3 quarters · filed 2021-11-22 | 186.00K shares 10-K · filed 2021-11-22 | ||
| 2021-06-30 | 18.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | 42.00K shares derived: sum of 2 quarters · filed 2021-08-05 | 186.00K shares 10-Q · filed 2021-08-05 | 350.00K shares derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2021-03-31 | 24.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-04 | 168.00K shares 10-Q · filed 2021-05-04 | 332.00K shares derived: sum of 3 quarters · filed 2021-05-04 | 466.00K shares derived: sum of 4 quarters · filed 2021-05-04 | ||
| 2020-12-31 | 144.00K shares 10-Q · filed 2021-02-04 | 308.00K shares derived: sum of 2 quarters · filed 2021-02-04 | 442.00K shares derived: sum of 3 quarters · filed 2021-02-04 | 874.50K shares derived: sum of 4 quarters · filed 2021-02-04 | ||
| 2020-09-30 | 164.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | 298.00K shares derived: sum of 2 quarters · filed 2020-11-23 | 730.50K shares derived: sum of 3 quarters · filed 2020-11-23 | 951.50K shares 10-K · filed 2020-11-23 | ||
| 2020-06-30 | 134.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | 566.50K shares derived: sum of 2 quarters · filed 2020-08-05 | 787.50K shares 10-Q · filed 2020-08-05 | 892.50K shares derived: sum of 4 quarters · filed 2020-08-05 | ||
| 2020-03-31 | 432.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | 653.50K shares 10-Q · filed 2020-05-07 | 758.50K shares derived: sum of 3 quarters · filed 2020-05-07 | 820.50K shares derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2019-12-31 | 221.00K shares 10-Q · filed 2020-02-05 | 326.00K shares derived: sum of 2 quarters · filed 2020-02-05 | 388.00K shares derived: sum of 3 quarters · filed 2020-02-05 | 1.05M shares derived: sum of 4 quarters · filed 2020-02-05 | ||
| 2019-09-30 | 105.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | 167.00K shares derived: sum of 2 quarters · filed 2019-11-25 | 832.50K shares derived: sum of 3 quarters · filed 2019-11-25 | 879.50K shares 10-K · filed 2019-11-25 | ||
| 2019-06-30 | 62.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | 727.50K shares derived: sum of 2 quarters · filed 2019-08-05 | 774.50K shares 10-Q · filed 2019-08-05 | 857.50K shares derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2019-03-31 | 665.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | 712.50K shares 10-Q · filed 2019-05-08 | 795.50K shares derived: sum of 3 quarters · filed 2019-05-08 | 874.50K shares derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2018-12-31 | 47.00K shares 10-Q · filed 2019-02-07 | 130.00K shares derived: sum of 2 quarters · filed 2019-02-07 | 209.00K shares derived: sum of 3 quarters · filed 2019-02-07 | 754.00K shares derived: sum of 4 quarters · filed 2019-02-07 | ||
| 2018-09-30 | 83.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | 162.00K shares derived: sum of 2 quarters · filed 2018-12-11 | 707.00K shares derived: sum of 3 quarters · filed 2018-12-11 | 822.00K shares 10-K · filed 2018-12-11 | ||
| 2018-06-30 | 79.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | 624.00K shares derived: sum of 2 quarters · filed 2018-08-07 | 739.00K shares 10-Q · filed 2018-08-07 | 739.00K shares derived: sum of 4 quarters · filed 2018-08-07 | ||
| 2018-03-31 | 545.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | 660.00K shares 10-Q · filed 2018-05-08 | 660.00K shares derived: sum of 3 quarters · filed 2018-05-08 | 725.00K shares derived: sum of 4 quarters · filed 2018-05-08 | ||
| 2017-12-31 | 115.00K shares 10-Q · filed 2018-02-09 | 115.00K shares derived: sum of 2 quarters · filed 2018-02-09 | 180.00K shares derived: sum of 3 quarters · filed 2018-02-09 | 705.00K shares derived: sum of 4 quarters · filed 2018-02-09 | ||
| 2017-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | 65.00K shares derived: sum of 2 quarters · filed 2017-12-12 | 590.00K shares derived: sum of 3 quarters · filed 2017-12-12 | 638.00K shares 10-K · filed 2017-12-12 | ||
| 2017-06-30 | 65.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | 590.00K shares derived: sum of 2 quarters · filed 2017-08-03 | 638.00K shares 10-Q · filed 2017-08-03 | 653.00K shares derived: sum of 4 quarters · filed 2017-08-03 | ||
| 2017-03-31 | 525.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-03 | 573.00K shares 10-Q · filed 2017-05-03 | 588.00K shares derived: sum of 3 quarters · filed 2017-05-03 | 595.00K shares derived: sum of 4 quarters · filed 2017-05-03 | ||
| 2016-12-31 | 48.00K shares 10-Q · filed 2017-02-06 | 63.00K shares derived: sum of 2 quarters · filed 2017-02-06 | 70.00K shares derived: sum of 3 quarters · filed 2017-02-06 | 1.37M shares derived: sum of 4 quarters · filed 2017-02-06 | ||
| 2016-09-30 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | 22.00K shares derived: sum of 2 quarters · filed 2016-12-14 | 1.32M shares derived: sum of 3 quarters · filed 2016-12-14 | 1.40M shares 10-K · filed 2016-12-14 | ||
| 2016-06-30 | 7.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | 1.30M shares derived: sum of 2 quarters · filed 2016-08-09 | 1.39M shares 10-Q · filed 2016-08-09 | 1.45M shares derived: sum of 4 quarters · filed 2016-08-09 | ||
| 2016-03-31 | 1.30M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | 1.38M shares 10-Q · filed 2016-05-10 | 1.44M shares derived: sum of 3 quarters · filed 2016-05-10 | 1.50M shares derived: sum of 4 quarters · filed 2016-05-10 | ||
| 2015-12-31 | 82.00K shares 10-Q · filed 2016-02-09 | 141.00K shares derived: sum of 2 quarters · filed 2016-02-09 | 202.00K shares derived: sum of 3 quarters · filed 2016-02-09 | 827.00K shares derived: sum of 4 quarters · filed 2016-02-09 | ||
| 2015-09-30 | 59.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | 120.00K shares derived: sum of 2 quarters · filed 2015-12-14 | 745.00K shares derived: sum of 3 quarters · filed 2015-12-14 | 1.73M shares 10-K · filed 2015-12-14 | ||
| 2015-06-30 | 61.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | 686.00K shares derived: sum of 2 quarters · filed 2015-08-04 | 1.67M shares 10-Q · filed 2015-08-04 | 1.78M shares derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2015-03-31 | 625.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | 1.61M shares 10-Q · filed 2015-05-11 | 1.72M shares derived: sum of 3 quarters · filed 2015-08-04 | 1.87M shares derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2014-12-31 | 984.00K shares 10-Q · filed 2015-02-09 | 1.09M shares derived: sum of 2 quarters · filed 2015-08-04 | 1.24M shares derived: sum of 3 quarters · filed 2015-08-04 | 1.92M shares derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2014-09-30 | 109.00K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2015-08-04 | 259.00K shares derived: sum of 2 quarters · filed 2015-08-04 | 934.00K shares derived: sum of 3 quarters · filed 2015-08-04 | 1.04M shares 10-Q · filed 2015-08-04 | ||
| 2014-06-30 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | 825.00K shares derived: sum of 2 quarters · filed 2014-08-12 | 930.00K shares 10-Q · filed 2014-08-12 | 1.49M shares derived: sum of 4 quarters · filed 2014-11-25 | ||
| 2014-03-31 | 675.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06 | 780.00K shares 10-Q · filed 2014-05-06 | 1.34M shares derived: sum of 3 quarters · filed 2014-11-25 | 2.21M shares derived: sum of 4 quarters · filed 2014-11-25 | ||
| 2013-12-31 | 105.00K shares 10-Q · filed 2014-02-04 | 665.17K shares derived: sum of 2 quarters · filed 2014-11-25 | 1.54M shares derived: sum of 3 quarters · filed 2014-11-25 | 1.62M shares derived: sum of 4 quarters · filed 2014-11-25 | ||
| 2013-09-30 | 560.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | 1.43M shares derived: sum of 2 quarters · filed 2014-11-25 | 1.51M shares derived: sum of 3 quarters · filed 2014-11-25 | 1.51M shares 10-K · filed 2014-11-25 | ||
| 2013-06-30 | 870.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | 953.00K shares derived: sum of 2 quarters · filed 2013-08-07 | 949.00K shares 10-Q · filed 2013-08-07 | 1.25M shares derived: sum of 4 quarters · filed 2014-05-06 | ||
| 2013-03-31 | 83.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | 79.00K shares 10-Q · filed 2013-05-09 | 384.00K shares derived: sum of 3 quarters · filed 2014-05-06 | |||
| 2012-12-31 | -4.00K shares 10-Q · filed 2013-02-13 | 301.00K shares derived: sum of 2 quarters · filed 2014-05-06 | ||||
| 2012-09-30 | 305.00K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-06 | 1.23M shares 10-Q · filed 2014-05-06 | ||||
| 2012-06-30 | 924.50K shares 10-Q · filed 2012-08-13 | |||||
| 2011-09-30 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | 20.00K shares 10-K · filed 2012-12-28 | ||||
| 2011-06-30 | 0.00 shares 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |